EN
DE 
NL 
FR 
ES 
IT 
CS 
PL CONDITION
Cannabinoids such as CBD and CBG, and the terpene beta-caryophyllene, show anti-inflammatory effects in laboratory and animal studies, partly through the CB2 receptor, but human evidence is still limited. Anti-inflammatory activity underlies much of the interest in cannabis for pain, arthritis and skin, but most of the evidence is still preclinical. It is a promising area, not a proven treatment.
What the research says
Several cannabinoids (including CBD and CBG) and the terpene beta-caryophyllene show anti-inflammatory effects in laboratory and animal studies, partly through the CB2 receptor and other pathways. Translating this into proven human treatments for specific inflammatory diseases is still largely work in progress.
Why the CB2 receptor matters
The endocannabinoid system’s CB2 receptor is heavily involved in immune and inflammatory responses, which is the mechanistic reason cannabinoids are studied for inflammation. Beta-caryophyllene is notable for binding it directly.
At a glance
What to be careful about
Inflammation is a symptom of many different conditions, some serious. Cannabis is not an established anti-inflammatory medicine, and persistent inflammation should be investigated properly.
Continue exploring
Immunological and pharmacological studies in Proceedings of the National Academy of Sciences (Gertsch et al., 2008, PMID 18574142), Future Medicinal Chemistry (Nagarkatti et al., 2009, PMID 20191092), and Antioxidants (Atalay et al., 2019, PMID 31888051) show that non-intoxicating cannabinoids (CBD, CBG, THCA) and the dietary sesquiterpene beta-caryophyllene modulate inflammatory cascades through peripheral CB2 receptors, PPAR-gamma nuclear receptors, and NF-kappaB suppression. While preclinical models of arthritis and colitis demonstrate robust cytokine reduction (TNF-alpha, IL-1beta, IL-6), human randomized trials remain smaller than for neuropathic pain.
Frequently Asked Questions
How do CB2 receptors regulate inflammation without causing intoxication?
CB2 receptors are expressed predominantly on peripheral immune cells (macrophages, B cells, and microglia) rather than central neurons, allowing selective CB2 agonists like beta-caryophyllene to downregulate cytokines without psychoactive effects.
What role do acidic cannabinoids like THCA and CBDA play in inflammation?
Preclinical studies show raw acidic cannabinoids (THCA and CBDA) inhibit COX-1/COX-2 enzymes and activate PPAR-gamma receptors before thermal decarboxylation.
How does CBD modulate oxidative stress and inflammatory cytokines?
CBD suppresses NF-kappaB transcription, activates Nrf2 antioxidant pathways, and reduces pro-inflammatory TNF-alpha and IL-6 signaling via adenosine A2A and TRPV1 receptors.
Sources & Immunological References
- Gertsch, J., Leonti, M., Raduner, S., et al. (2008). "Beta-caryophyllene is a dietary cannabinoid." Proceedings of the National Academy of Sciences, 105(26), 9099-9104. PubMed PMID 18574142.
- Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009). "Cannabinoids as novel anti-inflammatory drugs." Future Medicinal Chemistry, 1(7), 1333-1349. PubMed PMID 20191092.
- Atalay, S., Jarocka-Karpowicz, I., & Skrzydlewska, E. (2019). "Antioxidative and Anti-Inflammatory Properties of Cannabidiol." Antioxidants, 9(1), 21. PubMed PMID 31888051.
English